Insider Transactions Reported by 19 Insiders of Codiak BioSciences, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 14 Mar 2025

Codiak BioSciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Douglas E. Williams President & CEO, Director 28 Mar 2023
ARCH Venture Fund VIII, L.P. 10%+ Owner 13 Sep 2022
Flagship Ventures Fund V General Partner LLC 10%+ Owner 15 Sep 2022
Steven Gillis Director 16 Feb 2023
Anne-Virginie Eggimann Director 17 Jun 2022
Linda Bain Chief Financial Officer 28 Mar 2023
David J. Mauro Chief Medical Officer 24 Jan 2023
Karen Bernstein Director 16 Feb 2023
Jennifer J. Wheler Chief Medical Officer 10 May 2021
Sriram Sathyanarayanan Chief Scientific Officer 29 Mar 2023
Jason Haddock Director 16 Feb 2023
Arundathy N. Pandite Director 17 Jun 2022
Konstantin Konstantinov Chief Technology Officer 28 Mar 2023
Kyriazi Theo Melas Director 16 Feb 2023
Benny Sorensen Former SVP, Clinical Development 08 Jun 2021
Nicole Barna Senior Vice President, Human Resources 29 Mar 2023
Yalonda Howze Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary 30 Mar 2023
Richard Brudnick Officer title: Chief Business Officer and Head of Corporate Strategy 16 Feb 2022
COONEY CHARLES L Director 16 Feb 2023

Recent Insider Transactions by Companies or Individuals for Codiak BioSciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Yalonda Howze Common Stock Sale -17.9% -1,628 7,458 30 Mar 2023 Direct
Sriram Sathyanarayanan Common Stock Sale -100% -11,762 0 29 Mar 2023 Direct
Nicole Barna Common Stock Sale -60.1% -7,305 4,849 29 Mar 2023 Direct
Konstantin Konstantinov Common Stock Sale -100% -9,364 0 28 Mar 2023 Direct
Linda Bain Common Stock Sale -100% -13,412 0 28 Mar 2023 Direct
Douglas E. Williams Common Stock Sale -84.5% -41,667 7,655 28 Mar 2023 Direct
Konstantin Konstantinov Common Stock Sale -15.8% -1,391 7,432 17 Feb 2023 Direct
Sriram Sathyanarayanan Common Stock Sale -17% -2,407 11,762 17 Feb 2023 Direct
Nicole Barna Common Stock Sale -9.49% -1,274 12,154 17 Feb 2023 Direct
Yalonda Howze Common Stock Sale -15% -1,603 9,086 17 Feb 2023 Direct
Linda Bain Common Stock Sale -16.1% -2,570 13,412 17 Feb 2023 Direct
Douglas E. Williams Common Stock Sale -13.5% -7,681 49,322 17 Feb 2023 Direct
Jason Haddock Common Stock Options Exercise 8,750 8,750 16 Feb 2023 Direct
Jason Haddock Restricted Stock Units Options Exercise -100% -8,750 0 16 Feb 2023 Direct
Konstantin Konstantinov Common Stock Options Exercise 90.8% 4,200 8,823 16 Feb 2023 Direct
Konstantin Konstantinov Restricted Stock Units Options Exercise -33.3% -4,200 8,400 16 Feb 2023 Direct
Sriram Sathyanarayanan Common Stock Options Exercise 107.8% 7,350 14,169 16 Feb 2023 Direct
Sriram Sathyanarayanan Restricted Stock Units Options Exercise -33.3% -7,350 14,700 16 Feb 2023 Direct
Nicole Barna Common Stock Options Exercise 30.6% 3,150 13,428 16 Feb 2023 Direct
Nicole Barna Restricted Stock Units Options Exercise -33.3% -3,150 6,300 16 Feb 2023 Direct
Yalonda Howze Common Stock Options Exercise 83.2% 4,856 10,689 16 Feb 2023 Direct
Yalonda Howze Restricted Stock Units Options Exercise -33.3% -4,856 9,712 16 Feb 2023 Direct
Karen Bernstein Common Stock Options Exercise 8,750 8,750 16 Feb 2023 See footnote
Karen Bernstein Restricted Stock Units Options Exercise -100% -8,750 0 16 Feb 2023 See footnote
Linda Bain Common Stock Options Exercise 91% 7,613 15,982 16 Feb 2023 Direct
Linda Bain Restricted Stock Units Options Exercise -33.3% -7,613 15,224 16 Feb 2023 Direct
Steven Gillis Common Stock Options Exercise 8,750 8,750 16 Feb 2023 Direct
Steven Gillis Restricted Stock Units Options Exercise -100% -8,750 0 16 Feb 2023 Direct
Kyriazi Theo Melas Common Stock Options Exercise 132.6% 8,750 15,350 16 Feb 2023 Direct
Kyriazi Theo Melas Restricted Stock Units Options Exercise -100% -8,750 0 16 Feb 2023 Direct
Douglas E. Williams Common Stock Options Exercise 67.5% 22,969 57,003 16 Feb 2023 Direct
Douglas E. Williams Restricted Stock Units Options Exercise -33.3% -22,969 45,937 16 Feb 2023 Direct
Cooney Charles L Common Stock Options Exercise 8,750 8,750 16 Feb 2023 Direct
Cooney Charles L Restricted Stock Units Options Exercise -100% -8,750 0 16 Feb 2023 Direct
Sriram Sathyanarayanan Stock Option (Right to Buy) Award 140,000 140,000 24 Jan 2023 Direct
Konstantin Konstantinov Stock Option (Right to Buy) Award 145,000 145,000 24 Jan 2023 Direct
Yalonda Howze Stock Option (Right to Buy) Award 150,000 150,000 24 Jan 2023 Direct
Nicole Barna Stock Option (Right to Buy) Award 105,000 105,000 24 Jan 2023 Direct
David J. Mauro Stock Option (Right to Buy) Award 190,000 190,000 24 Jan 2023 Direct
Linda Bain Stock Option (Right to Buy) Award 185,000 185,000 24 Jan 2023 Direct
Douglas E. Williams Stock Option (Right to Buy) Award 465,000 465,000 24 Jan 2023 Direct
Konstantin Konstantinov Common Stock Sale -38.2% -1,069 1,731 20 Jan 2023 Direct
Sriram Sathyanarayanan Common Stock Sale -38.2% -1,082 1,752 20 Jan 2023 Direct
Yalonda Howze Common Stock Sale -37.8% -1,512 2,488 20 Jan 2023 Direct
Nicole Barna Common Stock Sale -9.34% -836 8,112 20 Jan 2023 Direct
Linda Bain Common Stock Sale -37.6% -1,880 3,120 20 Jan 2023 Direct
Douglas E. Williams Common Stock Sale -21.8% -5,075 18,177 20 Jan 2023 Direct
Konstantin Konstantinov Common Stock Options Exercise 2,800 2,800 19 Jan 2023 Direct
Konstantin Konstantinov Restricted Stock Units Options Exercise -33.3% -2,800 5,600 19 Jan 2023 Direct
Sriram Sathyanarayanan Common Stock Options Exercise 2,834 2,834 19 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.